These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9498075)

  • 1. Glycosylation and rheumatic disease.
    Axford JS
    Adv Exp Med Biol; 1998; 435():163-73. PubMed ID: 9498075
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosylation and rheumatic disease.
    Axford JS
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):219-29. PubMed ID: 10571014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The alterations of proteins glycosylation in rheumatic diseases].
    Chludzińska A; Chrostek L; Cylwik B
    Pol Merkur Lekarski; 2012 Aug; 33(194):112-6. PubMed ID: 23009010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation and rheumatic disease: more than icing on the cake.
    Axford JS
    J Rheumatol; 1994 Oct; 21(10):1791-5. PubMed ID: 7837139
    [No Abstract]   [Full Text] [Related]  

  • 5. An introduction to glycosylation and rheumatic disease. What is the current state of play?
    Axford JS; Alavi A
    Adv Exp Med Biol; 1995; 376():171-7. PubMed ID: 8597245
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in carbohydrate structure of IgG in rheumatoid arthritis.
    Roitt IM; Dwek RA; Parekh RB; Rademacher TW; Alavi A; Axford J; Bodman K; Bond A; Cooke A; Hay FC
    Recenti Prog Med; 1988; 79(7-8):314-7. PubMed ID: 3144028
    [No Abstract]   [Full Text] [Related]  

  • 7. Oligosaccharides: an optional extra or of relevance to disease mechanisms in rheumatology?
    Axford JS
    J Rheumatol; 1991 Aug; 18(8):1124-7. PubMed ID: 1941811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of disease-associated changes in the galactosylation of serum IgG.
    Parekh R; Isenberg D; Rook G; Roitt I; Dwek R; Rademacher T
    J Autoimmun; 1989 Apr; 2(2):101-14. PubMed ID: 2504180
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G.
    Jeddi P; Keusch J; Lydyard PM; Bodman-Smith KB; Chesnutt MS; Wofsy D; Hirota H; Taga T; Delves PJ
    Immunology; 1999 Nov; 98(3):475-80. PubMed ID: 10583610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of oligosaccharides to rheumatic disease: a personal perspective.
    Axford JS
    Glycoconj J; 1997 Nov; 14(7):863-6. PubMed ID: 9511992
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycobiology of the rheumatic diseases: an update.
    Alavi A; Axford J
    Adv Exp Med Biol; 2003; 535():271-80. PubMed ID: 14714902
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis.
    Furukawa K; Matsuta K; Takeuchi F; Kosuge E; Miyamoto T; Kobata A
    Int Immunol; 1990; 2(1):105-12. PubMed ID: 2128462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides.
    Watson M; Rudd PM; Bland M; Dwek RA; Axford JS
    Arthritis Rheum; 1999 Aug; 42(8):1682-90. PubMed ID: 10446868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant control of galactosyltransferase.
    Axford JS; Alavi A
    J Rheumatol; 1994 Nov; 21(11):2168-9. PubMed ID: 7869332
    [No Abstract]   [Full Text] [Related]  

  • 15. New insights into rheumatoid arthritis associated glycosylation changes.
    Alavi A; Pool AJ; Axford JS
    Adv Exp Med Biol; 2005; 564():129-38. PubMed ID: 16400819
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta 1,4-galactosyltransferase variations in rheumatoid arthritis.
    Alavi A; Axford J
    Adv Exp Med Biol; 1995; 376():185-92. PubMed ID: 8597247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine.
    Bond A; Alavi A; Axford JS; Bourke BE; Bruckner FE; Kerr MA; Maxwell JD; Tweed KJ; Weldon MJ; Youinou P; Hay FC
    J Autoimmun; 1997 Feb; 10(1):77-85. PubMed ID: 9080302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis.
    Bond A; Cooke A; Hay FC
    Eur J Immunol; 1990 Oct; 20(10):2229-33. PubMed ID: 2242757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation.
    Matsumoto A; Shikata K; Takeuchi F; Kojima N; Mizuochi T
    J Biochem; 2000 Oct; 128(4):621-8. PubMed ID: 11011144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance and molecular basis for IgG glycosylation changes in rheumatoid arthritis.
    Rademacher TW; Jones RH; Williams PJ
    Adv Exp Med Biol; 1995; 376():193-204. PubMed ID: 8597248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.